Search - tctmd.com

Displaying 661 - 680 of 1239

Sort: Relevancy | Date

Signal of Impaired Sapien XT Durability in Midterm Follow-up

News Conference News PCR London Valves 2019

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Michael O'Riordan

November 20, 2019

Two Small Series Support Role for Cerebral Protection in TAVR

News Conference News PCR London Valves 2019

Two Small Series Support Role for Cerebral Protection in TAVR

Michael O'Riordan

November 18, 2019

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

News Conference News AHA 2019

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

Yael L. Maxwell

November 18, 2019

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

News Conference News AHA 2019

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

November 17, 2019

Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY

News Conference News AHA 2019

Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY

Yael L. Maxwell

November 16, 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

November 11, 2019

Sapien 3 Valve Approved in Europe for Low-Risk Patients

News Daily News

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Michael O'Riordan

November 06, 2019

News Industry News

Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe

November 06, 2019

Show me the Data: Key Clinical Trials of 2019

Presentation Cardiovascular Interventions 2019

Show me the Data: Key Clinical Trials of 2019

Presenter: Ehtisham Mahmud

November 01, 2019

Cardioversion Without Anticoagulation Appears Safe in Patients With Watchman

News Daily News

Cardioversion Without Anticoagulation Appears Safe in Patients With Watchman

November 01, 2019

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

News Daily News

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

November 01, 2019

TCTMD’s Top 10 Most Popular Stories for October 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2019

October 31, 2019

Better Closure, More A-fib With Cardioform for PFO Closure: Retrospective Series

News Daily News

Better Closure, More A-fib With Cardioform for PFO Closure: Retrospective Series

Yael L. Maxwell

October 30, 2019

Gaps in Access to TAVR and SAVR: ‘Something Needs to Be Done’

News Daily News

Gaps in Access to TAVR and SAVR: ‘Something Needs to Be Done’

October 29, 2019

Cardiac Rehab Tied to Fewer Hospitalizations, Deaths After Valve Surgery

News Daily News

Cardiac Rehab Tied to Fewer Hospitalizations, Deaths After Valve Surgery

October 23, 2019

Presentation TCT Abstracts Posters 2019

Experience of Implantation of New Generation Self-expandable Transcatheter Aortic Valve Implantation in Patients with Low Surgical Risk

Presenter: Harol Hernández

October 13, 2019

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

News Conference News TCT 2019

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

October 09, 2019

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

News Daily News

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

October 08, 2019

Predicting Final Valve Position After TAVR: Different Devices, Different Success

News Conference News TCT 2019

Predicting Final Valve Position After TAVR: Different Devices, Different Success

Michael O'Riordan

October 07, 2019

Presentation TCT Abstracts Posters 2019

Transcatheter Aortic Valve Replacement in Low-risk Patients A Meta-analysis of Randomized Controlled Trials

Presenter: Ahmad Al-Abdouh

October 06, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.